News

This is Ask An Expert, where every weekday at 9:20am, KCBS Radio is giving you direct access to top experts in various fields. Today: Gene-editing technology allows scientists to work with DNA in unprecedented ways, but there are larger scientific...

For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.

Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...

Pronatalism is an old idea with roots in eugenics and nationalism, that is now fashionable among far-right influencers and policymakers. They talk...

This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Cynthia Fox, BioScience Technology | 02.25.2014
Even Teru Wakayama, a co-author on the Nature reprogramming papers that stunned the stem cell world this month, says he...
By Alejandra Dubcovsky, The Chronicle of Higher Education | 02.24.2014
I love the sciences. Because my father was a scientist, I grew up surrounded by talk of running gels, western...
By David Jensen, California Stem Cell Report | 02.23.2014
The California stem cell agency has put a little distance between it and its former chairman, Robert Klein, who is...
By Marcy Darnovsky, The New York Times | 02.23.2014

An advisory committee of the Food and Drug Administration is set to begin two days of meetings tomorrow to consider...

By Carole Cadwalladr, The Guardian | 02.22.2014
It's hard to know where to start with Ray Kurzweil. With the fact that he takes 150 pills a day...
By Robert Klitzman, CNN | 02.22.2014
Editor's note: Robert Klitzman is a professor of psychiatry and director of the Masters of Bioethics Program at Columbia University...
By Noreen Moustafa, Aljazeera America | 02.21.2014
In this week’s episode of “TechKnow,” we highlight the latest advances in forensic technology that are helping law enforcement agencies...
By Stuart A. Newman, Huffington Post | 02.20.2014
In a public meeting scheduled for February 25-26, the U.S. Food and Drug Administration (FDA) will consider approval of experiments...